Literature DB >> 2499202

Physiological activation of the mitochondrion and the transformation capacity of DFMO induced intermediate and short stumpy bloodstream form trypanosomes.

B F Giffin1, P P McCann.   

Abstract

Bloodstream forms of Trypanosoma brucei brucei (EATRO 110) were cultured with 100 microM difluoromethylornithine (DFMO). After 48 hr, intracellular putrescine was depleted and cells were positive when histochemically stained for the mitochondrial marker enzyme, NAD diaphorase, and exhibited mitochondrial proliferation and cristae development when examined by electron microscopy. This suggested that the mitochondrion was undergoing the physiological transformation necessary for successful transmission of the bloodstream form to the vector, namely the initiation of development of a TCA cycle and cytochrome system. The short stumpy forms that appeared by day 4 of culture, although physiologically transformed, were not viable in so far as they were not capable of transforming to procyclic trypomastigotes when introduced into SDM-79 medium. When rats infected with T. b. brucei were given 4% (w/v) DFMO in their drinking water, they were cured within 72 hr. Trypanosomes removed from animals and stained for NAD diaphorase showed mitochondrial transformation, as well as an intermediate and short stumpy morphology, at 36 and 60 hr, respectively. Data from this study on the growth and transformation characteristics of the DFMO induced intermediate and short stumpy form trypanosomes supports the observation that the intermediate form, and not the short stumpy form, is able to successfully transform to procyclic trypomastigotes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2499202     DOI: 10.4269/ajtmh.1989.40.487

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  6 in total

1.  Trypanocidal activity of a myristic acid analog in axenic cultures of Trypanosoma evansi.

Authors:  C A Ross; A M Taylor
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

2.  Studies on compounds promoting the in vitro transformation of Trypanosoma brucei from bloodstream to procyclic forms.

Authors:  M Hunt; R Brun; P Köhler
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

3.  Identification of a κ-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis.

Authors:  Deuan C Jones; Irene Hallyburton; Laste Stojanovski; Kevin D Read; Julie A Frearson; Alan H Fairlamb
Journal:  Biochem Pharmacol       Date:  2010-08-07       Impact factor: 5.858

Review 4.  The Cytological Events and Molecular Control of Life Cycle Development of Trypanosoma brucei in the Mammalian Bloodstream.

Authors:  Eleanor Silvester; Kirsty R McWilliam; Keith R Matthews
Journal:  Pathogens       Date:  2017-06-28

5.  Trypanosoma brucei PRMT1 Is a Nucleic Acid Binding Protein with a Role in Energy Metabolism and the Starvation Stress Response.

Authors:  Lucie Kafková; Chengjian Tu; Kyle L Pazzo; Kyle P Smith; Erik W Debler; Kimberly S Paul; Jun Qu; Laurie K Read
Journal:  mBio       Date:  2018-12-18       Impact factor: 7.867

Review 6.  Revisiting gametocyte biology in malaria parasites.

Authors:  Priscilla Ngotho; Alexandra Blancke Soares; Franziska Hentzschel; Fiona Achcar; Lucia Bertuccini; Matthias Marti
Journal:  FEMS Microbiol Rev       Date:  2019-07-01       Impact factor: 16.408

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.